Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis Smoker’s Cough Treatment Beats Glaxo’s Advair in Trial
Bloomberg Businessweek
Wednesday, August 29, 2012 - 10:49am
tags:
Novartis, COP, GSK, Advair, smoker's cough, QVA149
Synergy Acquires FV-100 from BMY
Yahoo/Zacks
Wednesday, August 29, 2012 - 10:38am
tags:
Bristol-Myers Squibb, FV-100, Synergy Pharmaceuticals, shingles
J&J's Zytiga to be reviewed faster by FDA for additional use
Reuters
Wednesday, August 29, 2012 - 10:37am
tags:
JNJ, Zytiga, FDA, prostate cancer
4 Low-Debt Pharmaceutical Stocks Backed By Analysts
Seeking Alpha
Wednesday, August 29, 2012 - 10:35am
tags:
Endocyte, Astex, Rigel Pharmaceuticals, Impax Labs
Abbott’s Humira Backed By FDA Advisory Panel For Colitis
Bloomberg
Wednesday, August 29, 2012 - 8:31am
tags:
Abbott, FDA, Humira, ulcerative colitis
Eli Lilly to stop developing schizophrenia drug
Yahoo/Reuters
Wednesday, August 29, 2012 - 8:30am
tags:
Eli Lilly, schizophrenia, pomaglumetad methionil
Stribild: It's FDA-Approved, but Will It Sell?
Motley Fool
Wednesday, August 29, 2012 - 8:29am
tags:
FDA, HIV, Gilead, Stribild
5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year
Seeking Alpha
Tuesday, August 28, 2012 - 12:27pm
tags:
Sucampo, Savient, Gentium, Alexza, Horizon Pharma
Medicines Co. says cardiology group guidelines recommend Angiomax over Heparin
Yahoo/Fly on the Wall
Tuesday, August 28, 2012 - 12:26pm
tags:
Medicines Company, Angiomax, Heparin, myocardial infarction
Isis Pharmaceuticals to receive $1.4 million from Alnylam
Yahoo
Tuesday, August 28, 2012 - 12:25pm
tags:
Isis Pharmaceuticals, Alnylam
Forest adopts 'poison pill' to fend off Icahn
Fierce Pharma
Tuesday, August 28, 2012 - 11:34am
tags:
Forest Labs, poison pill, Carl Icahn
Sanofi's Genzyme recalls kidney transplant rejection drug
Reuters
Tuesday, August 28, 2012 - 11:28am
tags:
Genzyme, kidney transplant, rejections, Sanofi, recalls, Thymoglobulin
ImmunoGen Rises On Partner Roche’s Results
Bloomberg
Tuesday, August 28, 2012 - 11:22am
tags:
breast cancer, Roche, Immunogen, T-DM1
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tuesday, August 28, 2012 - 11:07am
tags:
Cell Therapeutics, Momenta, Onyx, Amag Pharmaceuticals, Biomarin, M&A, Celgene, Seattle Genetics, Galena Biopharma, ImmunoCellular, Amgen, Celldex, Dendreon, GSK, Vical, Oncothyreon, Biogen Idec, Merck KGaA, Bristol-Myers Squibb, Allos, Spectrum Pharmaceuticals, AstraZeneca
Gilead pricing for Stribild makes sense, says Deutsche Bank
The Fly on the Wall
Tuesday, August 28, 2012 - 11:02am
tags:
HIV, Gilead, Stribild, pricing
Gilead’s 4-In-1 Stribild HIV Pill Wins U.S. FDA Approval
Bloomberg
Tuesday, August 28, 2012 - 10:56am
tags:
Gilead, FDA, HIV, Quad, Stribild
A New CEO for AstraZeneca
Motley Fool
Tuesday, August 28, 2012 - 10:55am
tags:
Pharma CEOs, AstraZeneca, Pascal Soriot, Roche
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tuesday, August 28, 2012 - 10:54am
tags:
Merck, Januvia, diabetes, AstraZeneca, Bristol-Myers Squibb, JNJ, Novartis, Sanofi, Takeda
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Seeking Alpha
Monday, August 27, 2012 - 5:27pm
tags:
Amylin, M&A, Bristol-Myers Squibb, Merck, Eli Lilly, AstraZeneca, diabetes
Merck will seek approval of 2 heart drugs in 2013
Yahoo/AP
Monday, August 27, 2012 - 5:26pm
tags:
Merck, Vorapaxar, bloodthinners, Tredaptive

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.